• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION Alinity I STAT High Sensitivity Troponin-I; Immunoassay Method, Troponin Subunit

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION Alinity I STAT High Sensitivity Troponin-I; Immunoassay Method, Troponin Subunit Back to Search Results
Catalog Number 04Z21-25
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/27/2026
Type of Reportable Event Malfunction
Event or Problem Description
The customer observed falsely elevated alinity i stat high sensitive troponin-i results on multiple male patients.The results provided were: on (b)(6) 2026 sid (b)(6): initial= 251.0 ng/l /repeated on alinity ai21537= <2.7 ng/l /repeated on (b)(6) 2026 on (b)(6)=3.0 and <2.7 ng/l redrawn and repeated after 2hrs on alinity (b)(6)= <2.7 ng/l redrawn and repeated after 4hrs on alinity (b)(6)= <2.7 ng/l sid (b)(6): initial= 232.2 ng/l /repeated on alinity ai21537= <2.7 ng/l /repeated on 30jun2026 on (b)(6)=<2.7 and <2.7 ng/l redrawn and repeated after 2hrs on alinity ai21531= <2.7 ng/l redrawn and repeated after 4hrs on alinity ai21531= <2.7 ng/l laboratory reference range for troponin=< 14.0 ng/l; critical cutoff= >200.0 ng/l there was no reported impact to patient management.
 
Additional Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.Section a patient information: refer to section b5 for complete patient information.All available patient information was included.Additional patient details are not available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
Alinity I STAT High Sensitivity Troponin-I
Common Device Name
Immunoassay Method, Troponin Subunit
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI  N39E932
Manufacturer (Section G)
Abbott Ireland Diagnostics Division
lisnamuck
co. longford
longford N39E9 32
EI   N39E932
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
+49()6122582960
MDR Report Key25797267
Report Number3005094123-2026-00338
Device Sequence Number5852655
Product Code MMI
UDI-Device Identifier00380740194062
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
K202525
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 09/21/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/12/2026
Device Catalogue Number04Z21-25
Device Lot Number87188UD00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/30/2026
Supplement Date Received by Manufacturer09/16/2026
Initial Report FDA Received Date07/13/2026
Supplement Report FDA Received Date09/21/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/30/2026
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ALNTY I PROCESSING MODU, 03R65-01, (B)(6)
Patient SexMale
-
-